Vorth TP Plus 50 mg/325 mg Tablet
By Vorth TP Plus
Rx
10 Tablet in a Strip

Composition
Tapentadol(50mg) + Paracetamol(325mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
June, 2026

liver
When using Vorth TP Plus 50 mg/325 mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Vorth TP Plus 50 mg/325 mg Tablet, so consult your doctor for guidance. It is not advised to use Vorth TP Plus 50 mg/325 mg Tablet in individuals with severe liver disease or active liver disease.

kidney
Vorth TP Plus 50 mg/325 mg Tablet should be used with caution in severe kidney disease. Dose adjustment may be necessary, so consult your doctor. Paracetamol in Vorth TP Plus 50 mg/325 mg Tablet is safe for kidney disease patients.

alcohol
It is not safe to drink alcohol while taking Vorth TP Plus 50 mg/325 mg Tablet. It is important to avoid alcohol when using this medication to ensure its effectiveness and avoid any potential risks.

driving
When taking Vorth TP Plus 50 mg/325 mg Tablet, be cautious while driving. Side effects like drowsiness, dizziness, blurred vision, or slow reaction time could impact your ability to drive safely. If you experience any of these, avoid driving.

pregnancy
During pregnancy, Vorth TP Plus 50 mg/325 mg Tablet may not be safe as animal studies suggest harm to the baby. Limited human studies exist, so consult your doctor to evaluate the risks and benefits before use.

breastfeeding
Vorth TP Plus 50 mg/325 mg Tablet should be avoided during breastfeeding as it may pass into breastmilk and harm the baby. It is recommended to consult a healthcare provider before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹156
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024